Saturday, 7 November 2026 कौन ज़िम्मेदार?
कौन ज़िम्मेदार?KaunZimmedar

Every story is a real government document.

Parliament Parliament Q&A

Ayush Nivesh Saarthi portal launched on 29 May 2025

The question asked about the 'AYUSH Nivesh Saarthi' initiative, details of traditional medicines produced, and MSME manufacturing units under the Ministry of Ayush.

Asked and answered by: Shri Anil Yeshwant Desai (asked), Ministry of Ayush (answered)

What the government said

  • Ayush Nivesh Saarthi portal launched on 29th May 2025
  • National List of Essential Ayush Medicines (NLEAM) published in 2022 with 201 Ayurveda, 200 Siddha, 200 Unani, 200 Homoeopathy drugs
  • State-wise total of Own Licensed Pharmacies under Ayush as on 01.04.2024: 8113 total
  • Details of people working not available

Also in the document

  • The answer states that details of people working in manufacturing units are not available.
  • The NLEAM includes specific numbers for each system (Ayurveda, Siddha, Unani, Homoeopathy).
  • The Annexure provides a detailed state-wise breakdown of pharmacies, totaling 8113 as of 01.04.2024.

How this was written

An AI model running on our own computer read the government document and wrote this summary. No person has checked it.

✓ Figures checked. Every number in this summary was found in the document by an automated check.

That check compares numbers only. It cannot confirm that the wording says what the document says — so the original document is always the authority.

How we work · Report an error in this story

The original document

Parliament of India — Questions & Answers (Lok Sabha, starred)

Question to govt · Ref. LS Q296 (Session 8) · 7 Aug 2026

Parliamentary Q&A 7 Aug 2026 · 0.2 MB Open the document On sansad.in ↗
Read it here

Discussion

Discuss the documents, not people. No doxxing of private individuals. Do not state allegations of crime or wrongdoing as fact — ask questions instead. Be civil. Posts that break these rules may be removed by moderators.

Sign in with Google to post

No one has discussed this document yet.